De­cen­tral­ized tri­als: FDA lays out its think­ing in new draft guid­ance

With the rise and in­creas­ing ac­cep­tance of cost-cut­ting and po­ten­tial­ly more di­verse de­cen­tral­ized clin­i­cal tri­als, the FDA on Tues­day un­veiled a new draft guid­ance on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER